José Garnacho‐Montero

Author

Hospital Universitario Virgen del Rocío ORCID

Also Known As

Amaia García Sagastume, Andreas Barratt-Due, Clara Rosso-Fernández, F. K. Borges, F. Logemann, G. Sevilla, Garnacho-Montero, Jose, George Dimopoulos, Izaskun Azkarate, J Garnacho Montero

549

Publications

17.4K

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen del Rocío Hospital Universitario Virgen Macarena Universidad de Sevilla Instituto de Biomedicina de Sevilla Hospital General Universitario Gregorio Marañón

About

José Garnacho‐Montero is an author at Hospital Universitario Virgen del Rocío specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	55	5.7K
2	Health Sciences	11	11	1.2K
3	Public Health	4	4	547
4	Social Sciences	1	1	26
5	Allergy	1	1	61

José Garnacho‐Montero

108

Publications

11.8K

Citations

H-Index

Page 1

	Year	Citations
Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis* José Garnacho‐Montero, J.L. García Garmendia, A Barrero-Almodóvar, Critical Care Medicine	2003	717
A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization* Cristóbal León, Sergio Ruiz‐Santana, Pedro Saavedra, Critical Care Medicine	2006	635
Treatment of Multidrug‐Resistant<i>Acinetobacter baumannii</i>Ventilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP José Garnacho‐Montero, Carlos Ortíz-Leyba, F. J. Jiménez-Jiménez, Clinical Infectious Diseases Antimicrobial SusceptibilityHealth SciencesAntibioticsImipenem‐susceptible VapIntravenous Colistin	2003	468
Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients José Garnacho‐Montero, Juan Madrazo-Osuna, J.L. García Garmendia, Intensive Care Medicine Critical Care MedicineClinical ConsequencesAcute CareClinical EpidemiologyPatient Safety	2001	399
De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock José Garnacho‐Montero, Ana Escoresca‐Ortega, Y. Corcia-Palomo, Intensive Care Medicine Critical Care MedicineSevere SepsisAcute CarePrognosisOutcomes Research	2013	386
Transfusion of Blood Components and Postoperative Infection in Patients Undergoing Cardiac Surgery Santiago R. Leal‐Noval, María D. Rincón-Ferrari, A. García-Curiel, CHEST Journal Cardiac AnaesthesiaCardiothoracic SurgeryBlood ComponentsTransfusion MedicineHematology	2001	359
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain Mireia Puig‐Asensio, B. Padilla, José Garnacho‐Montero, Clinical Microbiology and Infection Epidemiological TrendCandida Bloodstream InfectionsClinical EpidemiologyLate MortalityPopulation-based Surveillance	2013	281
Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy* José Garnacho‐Montero, Marcio Sa-Borges, Jordi Solé‐Violán, Critical Care Medicine	2007	280
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings José Garnacho‐Montero, Carlos Ortíz-Leyba, Esteban Fernández-Hinojosa, Intensive Care Medicine AntibioticsRespiratory InfectionInfectious Respiratory DiseaseVentilator-associated PneumoniaClinical Microbiology	2005	276
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality Matteo Bassetti, Elda Righi, Filippo Ansaldi, Intensive Care Medicine SepsisClinical InfectionClinical MycologySepsis PhenotypingSeptic Shock	2014	260

Page 1